A controversial dam in the Amazon unites Indigenous people and scientists, and transplanting mitochondria to treat rare diseases
Science Magazine Podcast
00:00
Exactly. And Did You See Improvements?
We chose mitochondria from their mothers, which we thought would be the safest for the patients. We knew that we'll have a major disadvantage that we cannot actually track them in the body. So what we had, we had surrogate markers. But they're not actual tracking goals. These cells are the or these mitochondria. Right? You want to see if you're seeing some improvement in the markers of what mitochondria do. Yeah. And did you? The first patient behaved like this was the real surprise. He just woke up, had more hours awake during the daytime,. Had more ability to carry out physical activity that was just remarkable.
Transcript
Play full episode
